Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 8, 2014

Primary Completion Date

October 24, 2017

Study Completion Date

April 30, 2018

Conditions
Pain Due to Certain Specified Procedures
Interventions
DRUG

intranasal fentanyl

During the two first sessions of care or rehabilitation, patients do not receive Pecfent® in order to assess their basal pain. During the following four sessions, patients will receive transmucosal fentanyl, 10 minutes before care. A titration of PecFent will be done at each session

Trial Locations (1)

38043

University hospital of Grenoble, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT02298582 - Safety of Intranasal Fentanyl (PecFent®) in the Treatment of Procedural Pain in the Elderly | Biotech Hunter | Biotech Hunter